Clinical Rheumatology

, Volume 37, Issue 4, pp 1111–1114 | Cite as

Comparison of composite indices with global synovitis score on ultrasound for detecting remission

  • Merve Ozata Olmez
  • Esen Kasapoglu Gunal
  • Sibel Bakirci Ureyen
  • Havva Keskin
  • Ayse Bilge Ozturk
  • Gokce Yeter
  • Erim Cobanoglu
  • Sibel Zehra Aydin
Brief Report


We aimed to compare composite indices with Ultrasound Global Synovitis Score (GLOESS) for remission in rheumatoid arthritis (RA). RA patients in remission according to the clinician were investigated with Disease Activity Score28 (DAS28), Clinical Disease Activity Index (CDAI), Simplified Disease Activity Index (SDAI), and RAPID-3 (Routine Assessment of Patient Index Data 3). Ultrasonography was performed using the GLOESS scores. Patients in CDAI-remission had lower GLOESS (median (IQR), 5(3–9.75) vs 7(4–11.75), p = 0.048) with a similar trend in SDAI (5(3–9.25) vs 7(4–11.25), p = 0.064). This was not observed with DAS28-CRP and RAPID3. Our results show that CDAI is superior to other indices to assess remission in RA.


CDAI RAPID3 Remission Rheumatoid arthritis SDAI US-GLOESS 


Compliance with ethical standards

Conflict of interest

SZA received grants and/or honoraria from Abbvie, Novartis, UCB, Sanofi and Pfizer.


  1. 1.
    Smolen JS, Aletaha D, Bijlsma JW et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631–637. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loët X, Maillefert JF (2012) Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Joint Bone Spine 79(2):149–155. CrossRefPubMedGoogle Scholar
  3. 3.
    Muñoz JGB, Giraldo RB, Santos AM, Bello-Gualteros JM, Rueda JC, Saldarriaga EL, Angarita JI, Arias-Correal S, Vasquez AY, Londono J (2017) Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis. Clin Rheumatol 36(5):1143–1148. CrossRefPubMedGoogle Scholar
  4. 4.
    Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P (2008) An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 58(10):2958–2967. CrossRefPubMedGoogle Scholar
  5. 5.
    Foltz V, Gandjbakhch F, Etchepare F, Rosenberg C, Tanguy ML, Rozenberg S, Bourgeois P, Fautrel B (2012) Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum 64(1):67–76. CrossRefPubMedGoogle Scholar
  6. 6.
    Balsa A, de Miguel E, Castillo C, Peiteado D, Martín-Mola E (2010) Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology (Oxford) 49:683–690CrossRefGoogle Scholar
  7. 7.
    D'Agostino MA, Wakefield RJ, Berner-Hammer H, Vittecoq O, Filippou G, Balint P, Möller I, Iagnocco A, Naredo E, Østergaard M, Boers M, Gaillez C, van Holder K, le Bars M, OMERACT-EULAR-Ultrasound Task Force (2016) Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study. Ann Rheum Dis 75(10):1763–1769. CrossRefPubMedGoogle Scholar
  8. 8.
    van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH (2011) Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum 63(1):37–42. CrossRefPubMedGoogle Scholar
  9. 9.
    Wakefield RJ, Balint PV, Szkudlarek M et al (2005) Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 32(12):2485–2487PubMedGoogle Scholar
  10. 10.
    Haugeberg G, Hansen IJ, Soldal DM, Sokka T (2015) Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Arthritis Res Ther 17(1):219. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Makinen H, Kautiainen H, Hannonen P, Sokka T (2005) Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 64(10):1410–1413. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Balsa A, de Miguel E, Castillo C, Peiteado D, Martin-Mola E (2010) Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology (Oxford) 49(4):683–690. CrossRefGoogle Scholar
  13. 13.
    Padovano I, Costantino F, Breban M, D'Agostino MA (2016) Prevalence of ultrasound synovial inflammatory findings in healthy subjects. Ann Rheum Dis 75(10):1819–1823. CrossRefPubMedGoogle Scholar
  14. 14.
    Dale J, Stirling A, Zhang R, Purves D, Foley J, Sambrook M, Conaghan PG, van der Heijde D, McConnachie A, McInnes IB, Porter D (2016) Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis 75(6):1043–1050. CrossRefPubMedGoogle Scholar
  15. 15.
    Haavardsholm EA, Aga AB, Olsen IC et al (2016) Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ 354:4205CrossRefGoogle Scholar
  16. 16.
    Han J, Geng Y, Deng X, Zhang Z et al (2016) Subclinical synovitis assessed by ultrasound predicts flare and progressive bone erosion in rheumatoid arthritis patients with clinical remission: a systematic review and metaanalysis. J Rheumatol 43(11):2010–2018. CrossRefPubMedGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2017

Authors and Affiliations

  1. 1.Department of Internal MedicineIstanbul Medeniyet University School of MedicineIstanbulTurkey
  2. 2.Division of RheumatologyIstanbul Medeniyet UniversityIstanbulTurkey
  3. 3.Division of RheumatologyUniversity of OttawaOttawaCanada
  4. 4.Division of Allergy and ImmunologyKoc UniversityIstanbulTurkey
  5. 5.School of MedicineKoc UniversityIstanbulTurkey
  6. 6.Division of Rheumatology, Ottawa Hospital Research InstituteUniversity of OttawaOttawaCanada

Personalised recommendations